tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Zai Lab’s Partner Amgen Halts Cancer Drug Trial Due to Efficacy Concerns
PremiumCompany AnnouncementsZai Lab’s Partner Amgen Halts Cancer Drug Trial Due to Efficacy Concerns
13d ago
Zai Lab removed from APAC Conviction List at Goldman Sachs
Premium
The Fly
Zai Lab removed from APAC Conviction List at Goldman Sachs
14d ago
Promising Clinical Results and Strategic Developments Drive Buy Rating for Zai Lab
Premium
Ratings
Promising Clinical Results and Strategic Developments Drive Buy Rating for Zai Lab
21d ago
Zai Lab’s Strategic Positioning and Competitive Edge in SCLC Treatment Justifies Buy Rating
PremiumRatingsZai Lab’s Strategic Positioning and Competitive Edge in SCLC Treatment Justifies Buy Rating
2M ago
Zai Lab Limited Announces Equity Incentive Grants
Premium
Company Announcements
Zai Lab Limited Announces Equity Incentive Grants
2M ago
Zai Lab Awaits Further Study Results Before Regulatory Filing
Premium
Company Announcements
Zai Lab Awaits Further Study Results Before Regulatory Filing
3M ago
Zai Lab to Review and Publish Interim Financial Results
PremiumCompany AnnouncementsZai Lab to Review and Publish Interim Financial Results
3M ago
Zai Lab’s Growth Potential and Global Expansion: A Strong Buy Recommendation
Premium
Ratings
Zai Lab’s Growth Potential and Global Expansion: A Strong Buy Recommendation
3M ago
Zai Lab price target raised to $69 from $66 at Citi
Premium
The Fly
Zai Lab price target raised to $69 from $66 at Citi
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100